The acquisition of AgBiome's assets by Ginkgo Bioworks is likely to have a positive short-term impact on Ginkgo's stock (DNA) due to the significant enhancement of its agricultural biologicals services and metagenomics database. This strategic move not only expands Ginkgo's product offerings but also strengthens its position in the biotech industry, potentially leading to increased investor confidence and market value.